Interplay between CD45RA+ regulatory T cells and TNF-α in the regulation of human Th17 differentiation

International Immunology

Volumn 22, Issue 4, 2010, Pages 237-244

  Baba, Nobuyasu ^a   Rubio, Manuel ^a   Sarfati, Marika ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Th17; TNF ; Treg

Indexed keywords

ALPHA INTERFERON; CD45RA ANTIGEN; INTERLEUKIN 17; INTERLEUKIN 22; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA;

ARTICLE; DENDRITIC CELL; HUMAN; HUMAN CELL; LYMPHOCYTE DIFFERENTIATION; MOLECULAR MECHANICS; PRIORITY JOURNAL; REGULATORY MECHANISM; REGULATORY T LYMPHOCYTE; T CELL DEPLETION; TH17 CELL;

EID: 77954051914     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxp130     Document Type: Article

References (55)

1. McGeachy, M. J. and Cua, D. J. 2008. Th17 cell differentiation: the long and winding road. Immunity 28:445.
2. Dong, C. 2008. TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat. Rev. Immunol. 8:337.
3. Hoffmann, P., Eder, R., Boeld, T. J. et al. 2006. Only the CD45RA+ subpopulation of CD4+CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion. Blood 108:4260.
4. Miyara, M., Yoshioka, Y., Kitoh, A. et al. 2009. Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 30:899.
5. Venken, K., Hellings, N., Broekmans, T., Hensen, K., Rummens, J. L. and Stinissen, P. 2008. Natural naive CD4+CD25+CD127low regulatory T cell (Treg) development and function are disturbed in multiple sclerosis patients: recovery of memory Treg homeostasis during disease progression. J. Immunol. 180:6411.
6. Nistala, K., Moncrieffe, H., Newton, K. R., Varsani, H., Hunter, P. and Wedderburn, L. R. 2008. Interleukin-17-producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbers. Arthritis Rheum. 58:875.
7. Costantino, C. M., Baecher-Allan, C. M. and Hafler, D. A. 2008. Human regulatory T cells and autoimmunity. Eur. J. Immunol. 38:921.
8. Michel, L., Berthelot, L., Pettre, S. et al. 2008. Patients with relapsing-remitting multiple sclerosis have normal Treg function when cells expressing IL-7 receptor alpha-chain are excluded from the analysis. J. Clin. Invest. 118:3411.
9. Bettelli, E., Carrier, Y., Gao, W. et al. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441:235.
10. Mangan, P. R., Harrington, L. E., O'Quinn, D. B. et al. 2006. Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441:231.
11. Yang, L., Anderson, D. E., Baecher-Allan, C. et al. 2008. IL-21 and TGF-beta are required for differentiation of human T(H)17 cells. Nature 454:350.
12. Korn, T., Bettelli, E., Gao, W. et al. 2007. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 448:484.
13. Acosta-Rodriguez, E. V., Napolitani, G., Lanzavecchia, A. and Sallusto, F. 2007. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 8:942.
14. Wilson, N. J., Boniface, K., Chan, J. R. et al. 2007. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat. Immunol. 8:950.
15. Manel, N., Unutmaz, D. and Littman, D. R. 2008. The differentiation of human T(H)-17 cells requires transforming growth factorbeta and induction of the nuclear receptor RORgammat. Nat. Immunol. 9:641.
16. Volpe, E., Servant, N., Zollinger, R. et al. 2008. A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses. Nat. Immunol. 9:650.
17. Laurence, A., Tato, C. M., Davidson, T. S. et al. 2007. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 26:371.
18. Zheng, Y., Danilenko, D. M., Valdez, P. et al. 2007. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445:648.
19. Veldhoen, M., Hirota, K., Christensen, J., O'Garra, A. and Stockinger, B. 2009. Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells. J. Exp. Med. 206:43.
20. Acosta-Rodriguez, E. V., Rivino, L., Geginat, J. et al. 2007. Surface phenotype and antigenic specificity of human interleukin 17producing T helper memory cells. Nat. Immunol. 8:639.
21. Chizzolini, C., Chicheportiche, R., Alvarez, M. et al. 2008. Prostaglandin E2 synergistically with interleukin-23 favors human Th17 expansion. Blood 112:3696.
22. Scheinecker, C., Redlich, K. and Smolen, J. S. 2008. Cytokines as therapeutic targets: advances and limitations. Immunity 28:440.
23. Valencia, X., Stephens, G., Goldbach-Mansky, R., Wilson, M., Shevach, E. M. and Lipsky, P. E. 2006. TNF downmodulates the function of human CD4+CD25hi T-regulatory cells. Blood 108:253.
24. Nadkarni, S., Mauri, C. and Ehrenstein, M. R. 2007. Anti-TNFalpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta. J. Exp. Med. 204:33.
25. Chen, Z. and O'Shea, J. J. 2008. Regulation of IL-17 production in human lymphocytes. Cytokine 41:71.
26. Demeure, C. E., Tanaka, H., Mateo, V., Rubio, M., Delespesse, G. and Sarfati, M. 2000. CD47 engagement inhibits cytokine production and maturation of human dendritic cells. J. Immunol. 164:2193.
27. Valmori, D., Merlo, A., Souleimanian, N. E., Hesdorffer, C. S. and Ayyoub, M. 2005. A peripheral circulating compartment of natural naive CD4 Tregs. J. Clin. Invest. 115:1953.
28. Ziolkowska, M., Koc, A., Luszczykiewicz, G. et al. 2000. High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism. J. Immunol. 164:2832.
29. McInnes, I. B. and Schett, G. 2007. Cytokines in the pathogenesis of rheumatoid arthritis. Nat. Rev. Immunol. 7:429.
30. van Beelen, A. J., Zelinkova, Z., Taanman-Kueter, E. W. et al. 2007. Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells. Immunity 27:660.
31. Zakharova, M. and Ziegler, H. K. 2005. Paradoxical antiinflammatory actions of TNF-alpha: inhibition of IL-12 and IL-23 via TNF receptor 1 in macrophages and dendritic cells. J. Immunol. 175:5024.
32. Notley, C. A., Inglis, J. J., Alzabin, S., McCann, F. E., McNamee, K. E. and Williams, R. O. 2008. Blockade of tumor necrosis factor in collagen-induced arthritis reveals a novel immunoregulatory pathway for Th1 and Th17 cells. J. Exp. Med. 205:2491.
33. Singh, S. P., Zhang, H. H., Foley, J. F., Hedrick, M. N. and Farber, J. M. 2008. Human T cells that are able to produce IL-17 express the chemokine receptor CCR6. J. Immunol. 180:214.
34. Bradshaw, E. M., Raddassi, K., Elyaman, W. et al. 2009. Monocytes from patients with type 1 diabetes spontaneously secrete proinflammatory cytokines inducing Th17 cells. J. Immunol. 183:4432.
35. Gerosa, F., Baldani-Guerra, B., Lyakh, L. A. et al. 2008. Differential regulation of interleukin 12 and interleukin 23 production in human dendritic cells. J. Exp. Med. 205:1447.
36. Scriba, T. J., Kalsdorf, B., Abrahams, D. A. et al. 2008. Distinct, specific IL-17and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response. J. Immunol. 180:1962.
37. Zheng, Y., Valdez, P. A., Danilenko, D. M. et al. 2008. Interleukin22 mediates early host defense against attaching and effacing bacterial pathogens. Nat. Med. 14:282.
38. Ishigame, H., Kakuta, S., Nagai, T. et al. 2009. Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity 30:108.
39. Sugimoto, K., Ogawa, A., Mizoguchi, E. et al. 2008. IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J. Clin. Invest. 118:534.
40. Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M. and Stockinger, B. 2006. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17producing T cells. Immunity 24:179.
41. Xu, L., Kitani, A., Fuss, I. and Strober, W. 2007. Cutting edge: regulatory T cells induce CD4+CD25-Foxp3T cells or are selfinduced to become Th17 cells in the absence of exogenous TGFbeta. J. Immunol. 178:6725.
42. Evans, H. G., Suddason, T., Jackson, I., Taams, L. S. and Lord, G. M. 2007. Optimal induction of T helper 17 cells in humans requires Tcell receptor ligation in the context of Toll-like receptor-activated monocytes. Proc. Natl Acad. Sci. USA 104:17034.
43. Koenen, H. J., Smeets, R. L., Vink, P. M., van Rijssen, E., Boots, A. M. and Joosten, I. 2008. Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells. Blood 112:2340.
44. Voo, K. S., Wang, Y. H., Santori, F. R. et al. 2009. Identification of IL-17-producing FOXP3+ regulatory T cells in humans. Proc. Natl Acad. Sci. USA 106:4793.
45. Santarlasci, V., Maggi, L., Capone, M. et al. 2009. TGF-beta indirectly favors the development of human Th17 cells by inhibiting Th1 cells. Eur. J. Immunol. 39:207.
46. Chen, X., Baumel, M., Mannel, D. N., Howard, O. M. and Oppenheim, J. J. 2007. Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells. J. Immunol. 179:154.
47. Charles, K. A., Kulbe, H., Soper, R. et al. 2009. The tumorpromoting actions of TNF-alpha involve TNFR1 and IL-17 in ovarian cancer in mice and humans. J. Clin. Invest. 119:3011.
48. Smith, A. M., Rahman, F. Z., Hayee, B. et al. 2009. Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease. J. Exp. Med. 206:1883.
49. Valesini, G., Iannuccelli, C., Marocchi, E., Pascoli, L., Scalzi, V. and Di Franco, M. 2007. Biological and clinical effects of antiTNFalpha treatment. Autoimmun. Rev. 7:35.
50. Song, I. H., Appel, H., Haibel, H. et al. 2008. New onset of Crohn's disease during treatment of active ankylosing spondylitis with etanercept. J. Rheumatol. 35:532.
51. Gomez-Gallego, M., Meca-Lallana, J. and Fernandez-Barreiro, A. 2008. Multiple sclerosis onset during etanercept treatment. Eur. Neurol. 59:91.
52. Selmaj, K. W. and Raine, C. S. 1988. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 23:339.
53. Selmaj, K. W., Farooq, M., Norton, W. T., Raine, C. S. and Brosnan, C. F. 1990. Proliferation of astrocytes in vitro in response to cytokines. A primary role for tumor necrosis factor. J. Immunol. 144:129.
54. TNF neutralization in MS: results of a randomized, placebocontrolled multicenter study. The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group. Neurology. 53:457.
55. Sutton, C., Brereton, C., Keogh, B., Mills, K. H. and Lavelle, E. C. 2006. A crucial role for interleukin (IL)-1 in the induction of IL-17producing T cells that mediate autoimmune encephalomyelitis. J. Exp. Med. 203:1685.